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Although keratinocytes have been mainly studied for their
barrier function (Madison, 2003), over the past 10 y the role
of keratinocytes as key immunocytes with very specific
immunomodulatory functions has been addressed. This
view was espoused by Nickoloff and Turka (1993) in their
editorial ‘‘Keratinocytes: Key immunocytes of the integu-
ment.’’ The review outlines three immune functions for the
keratinocyte when perturbed: a sentinel role through the
release of TNFa, an accessory role in the immune response
through the production of MHC class II molecules (Nickoloff
et al, 1985), and a target cell role through antigen presen-
tation to cytotoxic T cells. Although critical for maintaining
the barrier to water loss and pathogenic invasion, the ker-
atinocyte is also being examined for its accessory roles in
vitamin D production and immune surveillance.
The article by Xue et al (2005) in this issue expands the
idea that keratinocytes are multifunctional cells with a role in
immunomodulation through the activities of the endothelial
protein C receptor (EPCR). This receptor on endothelial cells
binds to protein C g-carboxy glutamic acid residues and
helps orient protein C for activation through thrombin-
thrombomodulin cleavage (Esmon, 2003). EPCR can also
bind activated protein C, which, through its protease activ-
ity, is able to cleave protease-activated receptor 1 (PAR-1),
generating an anti-inflammatory and anti-apoptotic re-
sponse (Dahlback and Villoutreix, 2005). This response is
thought to be mediated through mitogen-activated protein
kinase (MAPK) proteins, of which Xue’s article mentions the
increase in phosphorylation of the MAPK proteins p38 and
ERK2 following activated protein C treatment. It is interest-
ing to note that blocking EPCR with a blocking antibody
decreases the levels of these phosphorylated proteins to
near basal levels. Although the article attributes this to
MAPK signaling through the EPCR, it is also possible that
EPCR is required to anchor-activated protein C so that it
may cleave PAR-1; with EPCR blocked, activated protein C
is unable to activate PAR-1. Another indication that activat-
ed protein C activates MAPK through PAR-1 instead of
EPCR in keratinocytes is shown by the dose–responsive
decrease in keratinocyte proliferation when a PAR-1 anti-
body is applied.
When the barrier is disrupted, the keratinocyte becomes
activated in a number of different ways to return to homeo-
stasis. If the damage results in a discontinuity of the ep-
idermis, keratinocytes undergo a number of physical and
biochemical changes in order to migrate into the wound. The
signal for migration is thought to be through the release of
contact inhibition, signaling the cell to switch from a differ-
entiation phenotype (expressing keratins 5 and 14 in the
basal layer, or 1 and 10 in the superbasal layers) to a mi-
gration phenotype (expressing keratins 6 and 16). Keratin-
ocytes then migrate across the wound bed through the
actions of integrin receptors, binding to specific recognition
sequences in the granulation tissue (Grose et al, 2002). Once
the migration is complete, keratinocytes return to a differ-
entiation scheme. Keratinocyte growth factor (KGF) appears
to be the growth factor most closely associated with ker-
atinocyte migration; however, KGF knockout mice showed
no defect in wound healing (Guo et al, 1996). In addition to
migration, hyperproliferation occurs at the wound edge. Mi-
gration and hyperproliferation are thought to be the result of
cytokine and growth factor stimulation, and involve MAPK
signaling (Grose and Werner, 2002). This and other data
suggest that hyperproliferation and migration of keratin-
ocytes is controlled by multiple overlapping mechanisms, of
which EPCR or PAR-1 signaling may have a role.
The finding that EPCR are expressed in keratinocytes is a
significant follow-up to Jackson et al’s (2005) paper detailing
activated protein C as an important mediator of wound heal-
ing and angiogenesis. This article also suggests additional
studies that would further elucidate the keratinocyte response
during wound healing. Further examination of the role of
EPCR aiding in antigen presentation on keratinocytes was
mentioned in the text, and taking its structural similarity to
MHC class I molecules into account may be important in
determining its function in the keratinocyte (Liaw et al, 2001).
If blocking protein C binding to EPCR induces a shift in keratin
expression, it could also be implicated in a wound-healing
response. Further, the expression of EPCR in keratinocytes
isolated from chronic wounds could indicate a very important
role for this signaling cascade for chronic wound healing. It
would also be of interest to examine the role of protein C
inhibitor in keratinocytes, and the effects of retinoic acid on
this inhibition as suggested by Krebs et al (1999).
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